When acute myocarditis occurs in the setting of Lyme carditis, the underlying condition shapes the treatment approach. This protocol addresses that specific clinical scenario.
Lyme carditis is the condition driving myocardial involvement in this presentation. Recognising this as the primary aetiology is essential to selecting the appropriate treatment path.
The first-line approach involves intravenous antibiotic therapy.
DOI: 10.1093/eurheartj/ehaf192
Lyme carditis
i.v. antibiotics:
Cefotaxime (2 g q8h × 14–21 days) or Penicillin G (18–24 MU/day i.v. q4h × 14–21 days)
View source ↗